JPRN-jRCT2031210089已完成2 期
A phase II clinical study of KDT-3594 in Japanese patients with early Parkinson's disease.
Shimizu Yoshitaka0 个研究点目标入组 6 人开始时间: 2021年5月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 80age old（—）
- 性别
- All
入选标准
- •Patients who are diagnosed with Parkinson's disease according to UK Parkinson's Disease society brain bank clinical diagnostic criteria
- •-Patients with Parkinson's disease in Stages 1 to 3 on the Modified Hoehn and Yahr Scale
排除标准
- •-Patients who are suspected any parkinsonism except for idiopathic Parkinson's disease.
- •-Patients who underwent neurosurgical medical treatment (stereotaxic destruction, deep brain stimulation etc.) for PD, or patients for whom surgical treatment is scheduled during the study
- •-Patients with a complication of obvious dementia, or patients with Mini-Mental State Examination (MMSE) score < 24 points
研究者
相似试验
已完成
2 期
A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's DiseaseParkinson DiseaseNCT04867551Kissei Pharmaceutical Co., Ltd.7
已完成
1 期
A phase I clinical study of KSP-0243Healthy ConditionJPRN-jRCT2071200087Shimizu Yoshitaka144
已完成
2 期
A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.Parkinson DiseaseNCT03845387Kissei Pharmaceutical Co., Ltd.74
已完成
1 期
A Phase 1 Study of LY2835219 in Japanese Patients with Advanced Cancereoplasm Metastasis, LymphomaJPRN-jRCT2080222332Eli Lilly Japan K.K.
招募中
1 期
Clinical Pharmacology Study of KC-8025 in Japanese and Caucasian healthy adults (Phase I).JPRN-jRCT2071230101Yonemura Takuma48